← brief for 2026-11-02 · Slowing decline

Dysregulation of adipokines and inflammatory biomarkers in patients with metabolic syndrome and chronic kidney disease: A case-control study

Article C Peer reviewed Observational

Key takeaways

Researchers compared 60 people with both metabolic syndrome and kidney disease to 60 healthy people. They found differences in blood markers for inflammation. This shows a link, not proof of cause.

Who did this work

Latif Mosbah · Ahmed Al-Ziaydi

Source

Article · OpenAlex, CKD works · 2026-10-31
https://doi.org/10.38029/babcockuniv.med.j..v9is1.1625